CVD and diabetes prevention strategies aim to empower patients and improve health outcomes through personalized risk tools and collaboration.
The SHIELD project aims to enhance the prevention and management of CVD and diabetes through an innovative approach combining multimodal data collection, AI, and collaboration among healthcare stakeholders. By developing personalized risk stratification tools and care plans, SHIELD seeks to empower patients and improve outcomes. Clinical trials across Spain, Italy, and Switzerland will validate the tool’s effectiveness, while insights from this research will inform evidence-based health policies for broader population-wide impact in non- communicable disease prevention.
No takes yet. Share an insight, caveat, or question.
Cubillo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: